Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI
· Real-Time Price · USD
14.71
0.25 (1.73%)
At close: Aug 15, 2025, 3:59 PM
14.60
-0.71%
After-hours: Aug 15, 2025, 07:56 PM EDT
Denali Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | -305.04M | 1.27M | 294.12M | 35.14M | 10.28M | 3.56M | 52.48M | 42.14M | 12.51M | 5.29M | 22.94M | 7.92M |
Cost of Revenue | 3.04M | n/a | n/a | n/a | 1.94M | 2.16M | 2.18M | 2.22M | 1.36M | 9.17M | 3.23M | 1.28M | 1.23M | 1.3M | 1.31M | 71.56M | 65.71M | 60.21M |
Gross Profit | -3.04M | n/a | n/a | n/a | -1.94M | -2.16M | -307.22M | -950K | 292.77M | 25.97M | 7.05M | 2.28M | 51.25M | 40.84M | 11.2M | -66.27M | -42.77M | -52.28M |
Operating Income | -134.96M | -145.58M | -129.85M | -123.19M | -116.59M | -132.25M | -132.57M | -113.8M | 170.48M | -120.81M | -105.34M | -107.49M | -61.42M | -66.5M | -77.12M | -85.59M | -61.82M | -71.22M |
Interest Income | 10.84M | 12.61M | 15.16M | 15.99M | 17.57M | 15.91M | 13.13M | 14.44M | 12.9M | 11.03M | 6.66M | 4.19M | 2.65M | 1.28M | 1.28M | 1M | 1.13M | 1.18M |
Pretax Income | -124.12M | -132.97M | -114.69M | -107.19M | -99.03M | -101.8M | -119.44M | -99.35M | 183.38M | -109.78M | -98.68M | -103.3M | -58.77M | -65.22M | -75.84M | -84.59M | -60.69M | -70.04M |
Net Income | -124.12M | -132.97M | -114.75M | -107.19M | -99.03M | -101.8M | -119.47M | -99.35M | 183.38M | -109.78M | -98.68M | -103.3M | -58.79M | -63.94M | -75.26M | -84.59M | -60.69M | -70.04M |
Selling & General & Admin | 29.22M | 29.35M | 30.06M | 24.95M | 23.25M | 23.07M | 22.59M | 25.32M | 26.12M | 27.14M | 23.52M | 23.26M | 21.16M | 22.54M | 21.76M | 19.32M | 19.05M | 18.94M |
Research & Development | 102.7M | 116.23M | 99.79M | 98.24M | 91.4M | 107.02M | 107.8M | 89.74M | 97.52M | 128.82M | 92.11M | 87.79M | 92.74M | 86.1M | 67.88M | 71.56M | 65.71M | 60.21M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 131.92M | 145.58M | 129.85M | 123.19M | 114.65M | 130.09M | 130.4M | 115.06M | 123.64M | 155.96M | 115.63M | 111.05M | 113.9M | 108.64M | 89.64M | 90.88M | 84.76M | 79.14M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | 21.08M | n/a | n/a | n/a | 6.66M | 4.19M | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -1.94M | -2.16M | -2.18M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 134.96M | 145.58M | 138.05M | 123.19M | 116.59M | 132.25M | 132.57M | 115.06M | 123.64M | 155.96M | 115.63M | 111.05M | 113.9M | 108.64M | 89.64M | 90.88M | 84.76M | 79.14M |
Income Tax Expense | n/a | n/a | 68K | n/a | n/a | 2.12M | 30K | n/a | n/a | n/a | -6K | n/a | 27K | -1.28M | -575K | 782K | n/a | n/a |
Shares Outstanding (Basic) | 171.45M | 171.22M | 170.09M | 169.46M | 168.83M | 149.4M | 138.25M | 137.64M | 137.05M | 136.52M | 132.88M | 123.47M | 122.49M | 122.67M | 122.16M | 121.74M | 121.29M | 120.76M |
Shares Outstanding (Diluted) | 171.45M | 171.22M | 170.09M | 169.46M | 168.83M | 149.4M | 138.25M | 137.64M | 140.93M | 136.52M | 132.88M | 123.47M | 123.01M | 122.67M | 122.16M | 121.74M | 123.01M | 120.88M |
EPS (Basic) | -0.72 | -0.78 | -0.67 | -0.63 | -0.59 | -0.68 | -0.86 | -0.72 | 1.34 | -0.8 | -0.74 | -0.84 | -0.48 | -0.52 | -0.62 | -0.69 | -0.5 | -0.58 |
EPS (Diluted) | -0.72 | -0.78 | -0.67 | -0.63 | -0.59 | -0.68 | -0.86 | -0.72 | 1.30 | -0.8 | -0.74 | -0.84 | -0.48 | -0.52 | -0.62 | -0.69 | -0.49 | -0.58 |
EBITDA | -121.07M | -142.37M | -127.23M | -120.92M | -114.65M | -130.09M | -130.37M | -111.58M | 170.48M | -110.77M | -101.25M | -105.34M | -59.34M | -64.42M | -77.12M | -83.41M | -59.61M | -69.11M |
EBIT | -124.12M | -145.58M | -114.69M | -123.19M | -116.59M | -132.25M | -132.57M | -113.8M | 183.38M | -120.81M | -105.34M | -107.49M | -61.42M | -66.5M | -77.12M | -85.59M | -61.82M | -71.22M |
Depreciation & Amortization | 3.04M | 3.21M | 2.62M | 2.27M | 1.94M | 2.16M | 2.18M | 2.22M | 1.36M | 9.17M | 3.23M | 1.28M | 1.23M | 1.3M | 1.31M | 1.41M | 1.48M | 1.42M |